Medicines and Healthcare Products Regulatory Agency (Health) [2022] UKICO 117930 (26 May 2022)


BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?

No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!



BAILII [Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback]

Information Commissioner's Office
You are here: BAILII >> Databases >> Information Commissioner's Office >> Medicines and Healthcare Products Regulatory Agency (Health) [2022] UKICO 117930 (26 May 2022)
URL: http://www.bailii.org/uk/cases/UKICO/2022/117930.html
Cite as: [2022] UKICO 117930

[New search] [Printable PDF version] [Help]

Medicines and Healthcare Products Regulatory Agency

The complainant has requested information about adverse reactions to COVID-19 vaccines. The Medicines and Healthcare products Regulatory Agency (MHRA) originally relied on section 22 of FOIA to withhold the information, which concerns information intended for future publication. It subsequently withdrew its reliance on that exemption and is now withholding the requested information under section 40(2) and 41(1) of FOIA, which concern personal data and information provided in confidence respectively. The Commissioner’s decision is as follows: MHRA is entitled it withhold the requested information under section 41(1) of FOIA as it is information provided in confidence. The Commissioner does not require MHRA to take any remedial steps.

FOI 41: Complaint not upheld

Decision notice: 117930

BAILII: Copyright Policy | Disclaimers | Privacy Policy | Feedback | Donate to BAILII
URL: http://www.bailii.org/uk/cases/UKICO/2022/117930.html